Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 12, Issue 6, Pages 691-699
Publisher
Informa UK Limited
Online
2016-05-11
DOI
10.1080/17425255.2016.1187131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials
- (2015) Yun-Fa Jiang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glyburide Transport Across the Human Placenta
- (2015) Rachelle A. Schwartz et al. OBSTETRICS AND GYNECOLOGY
- Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes
- (2015) Wendy Camelo Castillo et al. JAMA Pediatrics
- Identification of CYP3A7 for glyburide metabolism in human fetal livers
- (2014) Diana L. Shuster et al. BIOCHEMICAL PHARMACOLOGY
- Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother WithKCNJ11-Related Neonatal Diabetes
- (2014) Nele Myngheer et al. DIABETES CARE
- Trends in Glyburide Compared With Insulin Use for Gestational Diabetes Treatment in the United States, 2000–2011
- (2014) Wendy Camelo Castillo et al. OBSTETRICS AND GYNECOLOGY
- The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988-2010
- (2013) S. Stark Casagrande et al. DIABETES CARE
- Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes
- (2012) Yvonne W. Cheng et al. Journal of Maternal-Fetal & Neonatal Medicine
- Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria
- (2012) Eliana M Wendland et al. BMC Pregnancy and Childbirth
- Patterns of Glycemia in Normal Pregnancy: Should the current therapeutic targets be challenged?
- (2011) T. L. Hernandez et al. DIABETES CARE
- Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG)
- (2011) D. A. Ogunyemi et al. DIABETIC MEDICINE
- Increased Glyburide Clearance in the Pregnant Mouse Model
- (2010) L. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Breast Cancer Resistance Protein (BCRP)-Mediated Glyburide Transport: Effect of the C421A/Q141K BCRP Single-Nucleotide Polymorphism
- (2010) E. K. Pollex et al. DRUG METABOLISM AND DISPOSITION
- Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice
- (2009) MF Hebert et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Glucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
- (2009) Ravi Retnakaran et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety of Glyburide for Gestational Diabetes: A Meta-Analysis of Pregnancy Outcomes
- (2008) Myla E Moretti et al. ANNALS OF PHARMACOTHERAPY
- The Role of Placental Breast Cancer Resistance Protein in the Efflux of Glyburide across the Human Placenta
- (2008) E. Pollex et al. PLACENTA
- Breast Cancer Resistance Protein: Mediating the Trans-placental Transfer of Glyburide across the Human Placenta
- (2007) C. Gedeon et al. PLACENTA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started